Back to AI News
arxiv

Causally Constrained and Uncertainty-Aware Cardiopulmonary Risk Prediction

Researchers introduce the Causal Envelope Agent (CE-Agent), a two-stage framework that compiles epidemiological evidence into constraints on risk-factor weights and estimates local baseline risk plus newly added CT phenotypes from cohort data. It uses closed-form uncertainty propagation to handle missing clinical or CT inputs in milliseconds and return calibrated risk intervals. Evaluated across 53,452 lung-screening participants and 6,814 multi-ethnic adults, CE-Agent outperformed cardiovascular calculators in lung screening, corrected Pooled Cohort Equations risk overestimation, generalized across hospitals and scanners, and matched lung cancer screening models.

AI Brief

The method offers a practical, uncertainty-aware approach to joint cardiopulmonary risk prediction that could improve screening triage and reduce overfitting in clinical AI.

arXiv:2611.17819v1 Announce Type: new Abstract: Routine chest computed tomography (CT) captures pulmonary, cardiac, and vascular phenotypes that jointly stratify lung cancer and cardiovascular disease, the two leading causes of death in lung-screening populations. Yet clinical risk calculators evaluate each disease in isolation and omit CT findings, whereas unconstrained machine learning overfits small hospital cohorts, learns treatment- and illness-confounded risk directions, and conceals uncertainty when patient records are incomplete. Here we present the Causal Envelope Agent (CE-Agent), a two-stage framework that compiles peer-reviewed epidemiological evidence into explicit constraints on risk-factor weights before any outcome is seen, while estimating local baseline risk and newly added CT phenotypes from cohort data. At deployment, closed-form uncertainty propagation accounts for missing clinical or CT inputs within milliseconds per patient, running over two orders of magnitude faster than Monte Carlo sampling and returning calibrated risk intervals that direct chart review and selective imaging to borderline patients. Across 53,452 lung-screening participants from 33 US hospitals and 6,814 multi-ethnic adults, CE-Agent outperforms cardiovascular calculators in lung screening, exceeds the Pooled Cohort Equations on hard atherosclerotic events while correcting their 1.7-fold risk overestimation, and generalizes from a single hospital or CT scanner to external sites while lowering required sample sizes up to fivefold. Applied unchanged to lung cancer, CE-Agent matches established screening models with accurate calibration even when restricted to risk-factor directions alone, and pairing both predictions improves joint cardiopulmonary triage from a single screening visit.
Be the first to rate this article.

Comments & Questions (0)

Captcha
Please be respectful — let's keep the conversation friendly.

No comments yet

Be the first to comment!